Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




No Added Value of MRI in RA Risk Stratification
Link ID 35367
Title No Added Value of MRI in RA Risk Stratification
Url http://www.medscape.com/viewarticle/740859?src=rss
Description Using magnetic resonance imaging (MRI) to help determine whether newly diagnosed rheumatoid arthritis (RA) patients will benefit from aggressive treatment is no more cost effective than standard risk stratification techniques, new research shows. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Apr 20, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Black Women With SLE Develop Cardiovascular Disease at Early Age
  Are black women with SLE more likely to develop heart disease, and, if so, why? Arthritis & Rheumatism Research News Alerts
Category:   Articles > Rheumatology


2. Polymyalgia Rheumatica Linked to Peripheral Artery Disease
  There is an increased risk of peripheral arterial disease (PAD) in patients with polymyalgia rheumatica, Minnesota-based researchers report in a March 31st online publication in Arthritis Research & Therapy. Reuters Health Information
Category:   Articles > Rheumatology


3. Progressive Atherosclerosis Complicates SLE
  Atherosclerosis commonly occurs and progresses in patients with systemic lupus erythematosus (SLE), according to a report in the October Arthritis & Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology


4. AMA Supports Latest Healthcare Reform Legislation With Reservations
  The American College of Physicians and the American Academy of Pediatrics also are backing the reform bill slated for a House vote on Sunday. Medscape Medical News
Category:   Articles > Rheumatology


5. FDA Panel Says No to Canakinumab for Gout AttacksFDA Panel Says No to Canakinumab for Gout Attacks
  For the FDA Arthritis Advisory Committee, the injectable biologic canakinumab may be promising for a niche group of patients, but fears about long-term safety kept them from voting for its approval. br / iMedscape Medical News/i
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS